Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Photobiomodulation mitigates doxorubicin resistance in MDA-MB-231 breast cancer cells: a promising avenue for overcoming chemoresistance

Although both wavelengths had considerable efficiency, at 630 nm, PBM performed better in overcoming DOX resistance.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied whether photobiomodulation at 630 nm and 980 nm could reduce doxorubicin resistance in MDA-MB-231 breast cancer cells grown in the laboratory. They report that combining light with doxorubicin lowered cell viability and reduced several resistance-related genes, with 630 nm performing better. These are cell-culture findings, so their relevance to patients is uncertain and further research is needed.

Who or what was studied
MDA-MB-231 breast cancer cells in vitro that had acquired doxorubicin resistance
Wavelengths
630, 980 nm
Limits stated in the abstract
The study used laboratory cell cultures, so the findings do not establish effects in humans and clinical potential remains unclear.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.

Record from PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
630 nm, 980 nm

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Low-level laser therapy, Light-emitting diode, Laser. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies